semaglutide ad Ozempic, Wegovy maker Novo Nordisk slams Hims & Hers Super Bowl for compounded GLP-1s What do you think of

Patients are encouraged to review the FDA's most current guidance on compounded GLP-1 products before starting treatment

However, only the 1.7 and 2.4 mg are approved for chronic weight management, while the first 3 doses are for titration only

For draws over 100 units, use a 1.5mL or 3mL syringe, or split the dose into two equal injections

It is designed to suppress your appetite, making it easier to stick to a healthy diet and shed unwanted fat

HSA and FSA accounts are eligible to cover your medication costs, making personalized care accessible and affordable

Key Findings: Participants: 338 obese adults Duration: 48 weeks Average weight loss: 17.5% to 24.2% depending on dose Metabolic improvements: Better insulin sensitivity, reduced inflammation markers These results put Retatrutide ahead of many current obesity drugs, making it one of the most promising new weight loss peptides of 2025